ArticleDiscover oncology2025
Single-cell RNA sequencing and traditional RNA sequencing reveals the role of cancer-associated fibroblasts in head and neck squamous cell carcinomas cohort.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Single-Cell Transcriptomics Identifies Novel Prognostic Signatures in HNSCC Immunotherapy Response.Cancer science · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHead and neck squamous cell carcinomas (HNSCs) are among the most common tumors worldwide. Despite the availability of various diagnostic and therapeutic strategies, the incidence and mortality rates of HNSC remain high. Cancer-associated fibroblasts (CAFs), as a major component of the tumor microenvironment, exhibit diverse biological characteristics in terms of origin, genetics, and phenotype, and have been increasingly recognized for their roles in tumor progression.
methodsTo investigate the potential role of CAFs in HNSC, we performed a comprehensive bioinformatics analysis based on the TCGA HNSC cohort. We applied single-sample gene set enrichment analysis (ssGSEA), single-cell RNA sequencing (scRNA-seq) analysis, differential expression analysis, Cox regression, LASSO regression, and pathway enrichment analysis to identify CAF-related genes and assess their prognostic value.
resultsWe successfully identified a set of CAF-related genes and stratified the HNSC patients into high- and low-CAF groups. Based on the expression of these genes, we constructed a prognostic prediction model using LASSO and multivariate Cox regression analyses. A nomogram integrating the risk score and clinical characteristics was developed to improve individualized survival prediction. Enrichment analysis revealed that the type I interferon signaling pathway, cellular response to type I interferon, defense response to symbiont, and extracellular matrix organization were significantly associated with CAFs in HNSC.
conclusionOur study provides a novel CAF-based prognostic model and nomogram for predicting patient outcomes in HNSC. These findings highlight the importance of CAFs in the tumor microenvironment and their potential as therapeutic and prognostic biomarkers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.